Danaher | DHR - Ebitda

Aktienkurs
180.60
Täglich Wechseln
3.35 1.89%
Monatlich
-1.79%
Jährlich
-7.81%
Q2 Prognose
173.46




Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio Techne USD 103.42M 7.47M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Boston Scientific USD 1.16B 213M 2025-12
Bruker USD 211.6M 207.4M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
ESCO Technologies USD 65.05M 28.28M 2025-12
Fortive USD 309.4M 21.4M 2025-09
Henry Schein USD 291M 4M 2025-12
Illumina USD 332M 12M 2025-09
Intuitive Surgical USD 1.09B 165.5M 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
Keysight Technologies USD 519M 71M 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
Medtronic USD 2.93B 482M 2025-12
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Quidel USD 153.3M 23.8M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Roper Industries USD 858.2M 39.2M 2025-12
Stryker USD 1.67B 206M 2025-09
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Waters USD 380.97M 85.83M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12